Historique
Auteur T. SOEIRO
Documents disponibles écrits par cet auteur (8)
Ajouter le résultat à votre sélection Affiner la recherche
C. GUERRA ; T. SOEIRO ; C. LACROIX ; E. JOUVE ; J. MICALLEF ; E. FRAUGER | 2022
Dans Therapies (Vol.77, n°6, Novembre-Décembre 2022) Article : PériodiqueFRANÇAIS : Objectif.- Le méthylphénidate est indiqué dans le trouble déficitaire de l'attention avec hyperactivité (TDAH). Plusieurs études ont évalué son abus dans des populations spécifiques (étudiants, usagers de drogues) et peu en populatio[...]
T. SOEIRO ; E. FRAUGER ; V. PRADEL ; J. MICALLEF | 2021
Dans Fundamental and Clinical Pharmacology (Vol.35, n°4, August 2021) Article : PériodiqueDoctor shopping enables subjects to receive more than the prescribed dose out of any medical management, which suggests a search for high doses and makes doctor shopping a relevant proxy for misuse and potential abuse. Therefore, this study aime[...]
A. ROUSSIN ; T. SOEIRO ; C. FOUQUE ; E. JOUANJUS ; E. FRAUGER ; N. FOUILHE ; M. MALLARET ; J. MICALLEF ; M. LAPEYRE-MESTRE ; French Addictovigilance Network | 2022
Dans British Journal of Clinical Pharmacology (Vol.88, n°8, August 2022) Article : PériodiqueAIM: To assess recent developments in non-medical tramadol use, tramadol use disorder, illegal procurement, and deaths. METHODS: Repeated cross-sectional analysis of data collected nationwide from 2013-2018. Analysis through the multisource mon[...]
T. SOEIRO ; A. DAVELUY ; C. VICTORRI-VIGNEAU ; M. LAPEYRE-MESTRE ; J. MICALLEF | 2025
Dans Therapies (Vol.80, n°2, Mars-Avril 2025) Article : PériodiqueThe French Addictovigilance Network has been using data from the French Heath insurance since the late 1990s to assess prescription drug abuse. In this narrative review, we illustrate the inputs of pharmacoepidemiology in addictovigilance based [...]
M. LAPEYRE-MESTRE ; C. BERTIN ; C. JALLES ; T. SOEIRO ; J. MICALLEF ; A. ROUSSIN | 2025
Dans Therapies (Vol.80, n°2, Mars-Avril 2025) Article : PériodiqueThe opioid epidemic has emerged in the USA in the late 1990s and widespread to Canada, Australia, and the UK to a lesser extent in the more recent years. At the European level, several studies performed in different European countries have highl[...]
P. GANDOLFO ; T. SOEIRO ; . JOUVE ; B. REVOL ; A. DAVELUY ; C. BERTIN ; C. EIDEN ; V. GIBAJA ; L. CHAOUACHI ; M. C. PERAULT-POCHAT ; C. CHEVALLIER ; A. AQUIZERATE ; R. LE BOISSELIER ; L. CARTON ; M. LAPEYRE-MESTRE ; E. FRAUGER ; C. LACROIX ; J. MICALLEF | 2024
Dans Fundamental and Clinical Pharmacology (Vol.38, n°5, October 2024) Article : PériodiqueBACKGROUND: Due to its psychoactive effects, ketamine has become a drug used for non-medical purpose. OBJECTIVES: To assess the latest trends in ketamine use among people with substance use disorder and to characterize its clinical complication[...]
C. M. GARNIER ; M. SCHEIN ; C. M. LACROIX ; E. JOUVE ; T. SOEIRO ; G. T. GENTILE ; M. LAPEYRE MESTRE ; J. L. MICALLEF | 2024
Dans CNS Drugs (Vol.38, n°9, September 2024) Article : PériodiqueIntroduction: In recent years, pregabalin has received growing attention due to its abuse liability. The aim of this study was to further characterize patterns of pregabalin users from substance abuse treatment facilities and detect changes in u[...]
T. SOEIRO ; V. PRADEL ; M. LAPEYRE-MESTRE ; J. MICALLEF | 2023
Dans Addiction (Vol.118, n°10, October 2023) Article : PériodiqueAIMS: The aim of this study was to present the first nation-wide, systematic, repeated assessment of doctor-shopping (i.e. visiting multiple physicians to be prescribed the same drug) during 10 years for more than 200 psychoactive prescription d[...]
